Hank Scheer's gripping medical thriller Fade to Blue has received the Literary Titan Book Award, recognizing the novel's high-stakes suspense, scientific intrigue, and morally charged exploration of discovery gone wrong. Blending the tension of a techno-thriller with the emotional weight of Alzheimer's research, Fade to Blue delivers a fast-paced story of ambition, fear, surveillance, and survival.
In Fade to Blue, Sarah Brenalen, a frustrated Alzheimer's researcher, secretly tests experimental drugs in hopes of making a breakthrough. Instead, she accidentally creates T-3, a compound capable of wiping out nearly all brain activity in moments. When Marcel, a polished and dangerous international operative, discovers the drug's potential, Sarah is pulled into a deadly cat-and-mouse game where her research, her freedom, and her life are all at stake.
Literary Titan praised the novel for its "clear and propulsive" prose and its ability to turn ordinary moments into scenes of mounting dread, noting how the story moves from Bay Area laboratories and freeway gambits to Paris, false deaths, and tactical reversals. The review recommends Fade to Blue to fans of techno-thrillers, medical thrillers, science-fiction thrillers, and suspense fiction, especially readers who enjoy the work of Michael Crichton and stories where scientific innovation becomes a terrifying threat.
The inspiration for Fade to Blue began in 1998, when Scheer was working at a steel mill in Pittsburg, California. After a manufacturing computer crash sparked the idea of a scientist creating a drug that could destroy a person's brain, Scheer began developing the premise that would eventually become his debut thriller. The novel was further shaped by personal experience, including his father's battle with Alzheimer's disease, and by research visits to neuroscience laboratories at UC Irvine and NYU.
With its blend of cutting-edge science, international conspiracy, and intimate psychological suspense, Fade to Blue asks urgent questions about scientific ambition, ethical responsibility, and how far powerful people will go to control a dangerous discovery.
Fade to Blue is available now. Readers can purchase the award-winning medical thriller on Amazon and Barnes & Noble.
About the Author
Hank Scheer is the author of Fade to Blue, a medical thriller inspired by real scientific research, personal experience, and a story idea born during a work break at a steel mill in Pittsburg, California. His writing journey began when a coworker suggested they write a short story together, eventually leading Scheer to imagine a drug capable of destroying the human brain. To develop the novel's scientific foundation, Scheer visited neuroscience laboratories at UC Irvine and NYU, drawing from firsthand conversations with researchers and from the emotional impact of his father's Alzheimer's disease. Now retired, Scheer lives in Martinez, California. He enjoys writing and recording music, world travel, biking, downhill skiing, and supporting working people fighting for a better world.
Email: hankscheer@gmail.com
Media Contact
Name
Literary Titan
Contact name
Henry Scheer
Country
United States
Url
https://amzn.to/4dbVw3V
COMTEX_479377668/2888/2026-05-18T09:32:17
